Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Sep. 8, 1999

Novel B-cell-selective immunomodulators useful in transplantation, autoimmune diseases

Sep. 6, 1999

Orally active prodigiosine compounds claimed for immunosuppression, Rx of T-cell leukemia-lymphoma

Sep. 3, 1999

PowderJect begins clinical study of DNA malaria vaccine

Sep. 3, 1999

Stanford team develops effective method for topical genetic immunization

Sep. 2, 1999

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Sep. 2, 1999

SciClone licenses new class of immunomodulators from University of California

Aug. 31, 1999

General Hospital Corp. discloses DNA vaccine for preventing, treating hepatitis C

Aug. 27, 1999

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aug. 27, 1999

Retrospective study supports safety of xenotransplantation

Aug. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...